Lower-Dose RT Effective in Aggressive Lymphomas

New findings support a shift away from the long-standing 30-Gy standard established before rituximab and PET response assessment.
Medscape Medical News

source https://www.medscape.com/viewarticle/lower-dose-rt-effective-aggressive-lymphomas-2025a1000s41?src=rss